The Relationship Between Anxiety, Depression and Treatment Adherence in Chronic Obstructive Pulmonary Disease: A Systematic Review

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Panagioti M, Scott C, Blakemore A, Coventry PA. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J COPD. 2014;9:1289–1306. doi:10.2147/COPD.S72073
   Google Scholar
• Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD J Chronic Obstr Pulm Dis. 2010;7(5):375–382. doi:10.3109/15412555.2010.510160
   Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15(12):1090–1096. doi:10.1002/1099-1166(200012)15:12<090::aid-gps249>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–1211. doi:10.1378/chest.127.4.1205
   PubMed Web of Science ®Google Scholar
• Phan T, Carter O, Waterer G, et al. Determinants for concomitant anxiety and depression in people living with chronic obstructive pulmonary disease. J Psychosom Res. 2019;120:60–65. doi:10.1016/j.jpsychores.2019.03.004
   PubMed Web of Science ®Google Scholar
• Biswas D, Mukherjee S, Chakroborty R, et al. Occurrence of anxiety and depression among stable COPD patients and its impact on functional capability. J Clin Diagnostic Res. 2017;11(2):OC24–OC27. doi:10.7860/JCDR/2017/24203.9393
   PubMed Web of Science ®Google Scholar
• Tetikkurt C, Ozdemir I, Tetikkurt S, Yilmaz N, Ertan T, Bayar N. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Respir Med. 2011;6(4):226–231. doi:10.1186/2049-6958-6-4-226
   PubMed Web of Science ®Google Scholar
• Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5):858–866. doi:10.4187/respcare.01862
   PubMed Web of Science ®Google Scholar
• Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 suppl):43S–56S. doi:10.1378/chest.08-0342
   PubMed Web of Science ®Google Scholar
• Dowson C, Laing R, Barraclough R, et al. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J. 2001;114(1141):447–449.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–1221. doi:10.1002/gps.2463
   PubMed Web of Science ®Google Scholar
• Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012;185(9):918–923. doi:10.1164/rccm.201105-0939PP
   PubMed Web of Science ®Google Scholar
• Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–67. doi:10.1001/archinte.167.1.60
   PubMed Web of Science ®Google Scholar
• Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766–777. doi:10.1378/chest.12-1911
   PubMed Web of Science ®Google Scholar
• Giardino ND, Curtis JL, Andrei AC, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res. 2010;11(1):29. doi:10.1186/1465-9921-11-29
   PubMedGoogle Scholar
• Blakemore A, Dickens C, Guthrie E, et al. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J COPD. 2014;9:501–512. doi:10.2147/COPD.S58136
   Google Scholar
• Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349. doi:10.1183/09059180.00007813
   PubMedGoogle Scholar
• Sundh J, Ekström M. Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J COPD. 2016;11(1):2805–2812. doi:10.2147/COPD.S119992
   Google Scholar
• Yohannes AM, Müllerová H, Hanania NA, et al. Long-term course of depression trajectories in patients with COPD: a 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. Chest. 2016;149(4):916–926. doi:10.1016/j.chest.2015.10.081
   PubMed Web of Science ®Google Scholar
• Burgel. PR, Escamilla R, Perez T, et al. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013;107(2):233–241.
   PubMed Web of Science ®Google Scholar
• Von Leupoldt A, Kenn K. The psychology of chronic obstructive pulmonary disease. Curr Opin Psychiatry. 2013;26(5):458–463. doi:10.1097/YCO.0b013e328363c1fc
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleveland Clin J Med. 2018;85(2 Suppl 1):S11–S18.
   PubMed Web of Science ®Google Scholar
• Fan VS, Giardino ND, Blough DK, et al. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD J Chronic Obstr Pulm Dis. 2008;5(2):105–116. doi:10.1080/15412550801941190
   Web of Science ®Google Scholar
• Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012;68(10):1365–1373. doi:10.1007/s00228-012-1279-5
   PubMed Web of Science ®Google Scholar
• Wang KY, Sung PY, Yang ST, Chiang CH, Perng WC. Influence of family caregiver caring behavior on COPD Patients’ self-care behavior in Taiwan. Respir Care. 2012;57(2):263–272. doi:10.4187/respcare.00986
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(2101):2107. doi:10.1001/archinte.160.14.2101
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366. doi:10.1136/bmj.l4898
   Web of Science ®Google Scholar
• Sirey JA, Raue PJ, Alexopoulos GS. An intervention to improve depression care in older adults with COPD. Int J Geriatr Psychiatry. 2007;22(2):154–159. doi:10.1002/gps.1705
   PubMed Web of Science ®Google Scholar
• Torheim H, Gjengedal E. How to cope with the mask? Experiences of mask treatment in patients with acute chronic obstructive pulmonary disease-exacerbations. Scand J Caring Sci. 2010;24(3):499–506. doi:10.1111/j.1471-6712.2009.00740.x
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Kiosses DN, Sirey JA, et al. Personalised intervention for people with depression and severe COPD. Br J Psychiatry. 2013;202(3):235–236. doi:10.1192/bjp.bp.112.120139
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Kiosses DN, Sirey JA, et al. Untangling therapeutic ingredients of a personalized intervention for patients with depression and severe COPD. Am J Geriatr Psychiatry. 2014;22(11):1316–1324. doi:10.1016/j.jagp.2013.05.006
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Sirey JA, Banerjee S, et al. Two behavioral interventions for patients with major depression and severe COPD. Am J Geriatr Psychiatry. 2016;24(11):964–974. doi:10.1016/j.jagp.2016.07.014
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Sirey JA, Banerjee S, et al. Two interventions for patients with major depression and severe chronic obstructive pulmonary disease: impact on dyspnea-related disability. Am J Geriatr Psychiatry. 2018;26(2):162–171. doi:10.1016/j.jagp.2017.10.002
   PubMed Web of Science ®Google Scholar
• Jackson DS, Banerjee S, Sirey JA, et al. Two interventions for patients with major depression and severe chronic obstructive pulmonary disease: impact on quality of life. Am J Geriatr Psychiatry. 2019;27(5):502–511. doi:10.1016/j.jagp.2018.12.004
   PubMed Web of Science ®Google Scholar
• Albrecht JS, Khokhar B, Huang TY, et al. Adherence and healthcare utilization among older adults with COPD and depression. Respir Med. 2017;129:53–58. doi:10.1016/j.rmed.2017.06.002
   PubMed Web of Science ®Google Scholar
• Busch AM, Scott-Sheldon LAJ, Pierce J, et al. Depressed mood predicts pulmonary rehabilitation completion among women, but not men. Respir Med. 2014;108(7):1007–1013. doi:10.1016/j.rmed.2014.04.010
   PubMed Web of Science ®Google Scholar
• Heerema-Poelman A, Stuive I, Wempe JB. Adherence to a maintenance exercise program 1 year after pulmonary rehabilitation: what are the predictors of dropout? J Cardiopulm Rehabil Prev. 2013;33(6):419–426. doi:10.1097/HCR.0b013e3182a5274a
   PubMed Web of Science ®Google Scholar
• Zucchelli A, Vetrano DL, Bianchini E, et al. Adherence to COPD free triple inhaled therapy in the real world: a primary care based study. Clin Respir J. 2020;14(8):732–739. doi:10.1111/crj.13190
   PubMed Web of Science ®Google Scholar
• Chen Z, Fan VS, Belza B, Pike K, Nguyen HQ. Association between social support and self-care behaviors in adults with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(9):1419–1427. doi:10.1513/AnnalsATS.201701-026OC
   PubMed Web of Science ®Google Scholar
• Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9(11):2346–2350. doi:10.1183/09031936.96.09112346
   PubMed Web of Science ®Google Scholar
• Albrecht JS, Park Y, Hur P, et al. Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease the role of depression. Ann Am Thorac Soc. 2016;13(9):1497–1504. doi:10.1513/AnnalsATS.201602-136OC
   PubMed Web of Science ®Google Scholar
• Wei YJ, Simoni-Wastila L, Albrecht JS, et al. The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: a longitudinal cohort study. Int J Geriatr Psychiatry. 2018;33(2):e212–e220. doi:10.1002/gps.4772
   PubMed Web of Science ®Google Scholar
• Kokturk N, Polatli M, Oguzulgen IK, et al. Adherence to COPD treatment in turkey and Saudi Arabia: results of the ADCARE study. Int J COPD. 2018;13:1377–1388. doi:10.2147/COPD.S150411
   Google Scholar
• Pierobon A, Bottelli ES, Ranzini L, et al. COPD patients’ self-reported adherence, psychosocial factors and mild cognitive impairment in pulmonary rehabilitation. Int J COPD. 2017;12:2059–2067. doi:10.2147/COPD.S133586
   Google Scholar
• Jarab AS, Mukattash TL. Exploring variables associated with medication non-adherence in patients with COPD. Int J Clin Pharm. 2019;41(5):1202–1209. doi:10.1007/s11096-019-00895-3
   PubMed Web of Science ®Google Scholar
• Choi JY, Chung HIC, Han G. Patient outcomes according to COPD action plan adherence. J Clin Nurs. 2014;23(5–6):883–891. doi:10.1111/jocn.12293
   PubMed Web of Science ®Google Scholar
• Dowson CA, Town GI, Frampton C, Mulder RT. Psychopathology and illness beliefs influence COPD self-management. J Psychosom Res. 2004;56(3):333–340. doi:10.1016/S0022-3999(03)00040-0
   PubMed Web of Science ®Google Scholar
• Turan O, Yemez B, Itil O. The effects of anxiety and depression symptoms on treatment adherence in COPD patients. Prim Health Care Res Dev. 2014;15(3):244–251. doi:10.1017/S1463423613000169
   PubMed Web of Science ®Google Scholar
• Gauthier A, Bernard S, Bernard E, Simard S, Maltais F, Lacasse Y. Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2018;16:1479972318767724. doi:10.1177/1479972318767724
   Web of Science ®Google Scholar
• Qian J, Simoni-Wastila L, Rattinger GB, et al. Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2014;29(1):49–57. doi:10.1002/gps.3968
   PubMed Web of Science ®Google Scholar
• Doyle C, Dunt D, Ames D, Selvarajah S. Managing mood disorders in patients attending pulmonary rehabilitation clinics. Int J COPD. 2013;8:15–20. doi:10.2147/COPD.S36378
   Google Scholar
• Zareifopoulos N, Bellou A, Spiropoulou A, Spiropoulos K. Prevalence, contribution to disease burden and management of comorbid depression and anxiety in chronic obstructive pulmonary disease: a narrative review. COPD J Chronic Obstr Pulm Dis. 2019;16(5–6):406–417. doi:10.1080/15412555.2019.1679102
   PubMed Web of Science ®Google Scholar
• Hogea SP, Tudorache E, Fildan AP, Fira-Mladinescu O, Marc M, Oancea C. Risk factors of chronic obstructive pulmonary disease exacerbations. Clin Respir J. 2020;14(3):183–197. doi:10.1111/crj.13129
   PubMed Web of Science ®Google Scholar
• Ranzini L, Schiavi M, Pierobon A, Granata N, Giardini A. From Mild Cognitive Impairment (MCI) to Dementia in Chronic Obstructive Pulmonary Disease. Implications for clinical practice and disease management: a mini-review. Front Psychol. 2020;11(February):1–6. doi:10.3389/fpsyg.2020.00337
   PubMedGoogle Scholar
• Alexopoulos GS, Latoussakis V. Depression comorbidity with COPD. Psychiatr Ann. 2004;34(4):289–296. doi:10.3928/0048-5713-20040401-09
   Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986;24:1–8. doi:10.1016/0005-7967(86)90143-9
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi:10.1001/archinte.166.10.1092
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. doi:10.1136/jnnp.23.1.56
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. Vols. 1-82. San Antonio, TX: Psychol Corp; 1996.
   Google Scholar
• Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–1744.
   PubMed Web of Science ®Google Scholar
• Goldberg DP. The detection of psychiatric illness by questionnaire; a technique for the identi-fication and assessment of non-psychotic illness. Can Psychiatr Assoc J. 1972;18(4):348–349.
   Google Scholar
• Willgoss TG, Goldbart J, Fatoye F, Yohannes AM. The development and validation of the anxiety inventory for respiratory disease. Chest. 2013;144(5):1587–1596. doi:10.1378/chest.13-0168
   PubMed Web of Science ®Google Scholar
• Kühl K, Kuhn C, Kenn K, Rief W. The COPD-anxiety-questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients. PPmP - Psychother · Psychosom · Medizinische Psychol. 2011;61(1):e1–9. doi:10.1055/s-0030-1248281
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31(7):483–492. doi:10.1007/s40266-014-0186-0
   PubMed Web of Science ®Google Scholar
• Matthews G, Jones DM, Chamberlain AG. Refining the measurement of mood: the UWIST Mood Adjective Checklist. Br J Psychol. 1990;81(1):17–42. doi:10.1111/j.2044-8295.1990.tb02343.x
   Web of Science ®Google Scholar
• Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–396. doi:10.2307/2136404
   PubMed Web of Science ®Google Scholar
• Rabin R, De Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–343. doi:10.3109/07853890109002087
   PubMed Web of Science ®Google Scholar
• Spielberger CD, Gorsuch RL, Lushene RE. STAI Manual for the State-Trait Anxiety Inventory. Self-Evaluation Questionnaire. Palo Alto, CA: Consulting Psychologists Press; 1970.
   Google Scholar
• Alexopoulos GS, Raue PJ, Sirey JA, Arean PA. Developing an intervention for depressed, chronically medically ill elders: a model from COPD. Int J Geriatr Psychiatry. 2008;23(5):447–453. doi:10.1002/gps.1925
   PubMed Web of Science ®Google Scholar
• Bhattarai B, Walpola R, Mey A, Anoopkumar-Dukie S, Khan S. Barriers and strategies for improving medication adherence among people living with COPD: a systematic review. Respir Care. 2020;65(11):1738–1750. doi:10.4187/respcare.07355
   PubMed Web of Science ®Google Scholar
• Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD J Chronic Obstr Pulm Dis. 2005;2(1):185–193. doi:10.1081/COPD-200050740
   Google Scholar
• Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49. doi:10.1016/0022-3956(82)90033-4
   PubMed Web of Science ®Google Scholar
• Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. doi:10.1177/014662167700100306
   Web of Science ®Google Scholar
• Spitzer RL, Williams J, Gibbon W, First MB. User’s guide for the Structured Clinical Interview for DSM-IIIR (SCID). Am Psychiatr. 1990;272:1749–1756.
   Google Scholar
• Zung WWK. A self-rating depression scale. Arch Gen Psychiatry. 1965;12(1):63–70. doi:10.1001/archpsyc.1965.01720310065008
   PubMed Web of Science ®Google Scholar
• Evans ME. Development and validation of a brief screening scale for depression in the elderly physically ill. Int Clin Psychopharmacol. 1993;8(4):329–331. doi:10.1097/00004850-199300840-00022
   PubMed Web of Science ®Google Scholar
• Copeland JR, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med. 1986;16(1):89–99. doi:10.1017/S0033291700057779
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389. doi:10.1192/bjp.134.4.382
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi:10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Majani G, Pierobon A, Giardini A, Callegari S. Valutare e Favorire L’aderenza Alle Prescrizioni in Riabilitazione Cardiologica e Pneumologica. (Maugeri IM Della F, Ed.). Pime; 2007.
   Google Scholar
• Kaplan A. The COPD action plan. Can Fam Physician. 2009;55:58–59.
   PubMed Web of Science ®Google Scholar
• Van Der Palen J, Klein JJ, Van Herwaarden CLA, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma patients. Eur Respir J. 1999;14(5):1034–1037. doi:10.1183/09031936.99.14510349
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32.
   Web of Science ®Google Scholar
• Delgado A, Lima M. Contributo para a validação concorrente de uma medidade de adesão aos tratamentos. Psicol Saúde Doenças. 2001;2:81–100.
   Google Scholar
• Plaza V, Fernández-Rodríguez C, Melero C, et al. Validation of the “Test of the Adherence to Inhalers” (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/jamp.2015.1212
   PubMed Web of Science ®Google Scholar